Pfizer and Flagship Pioneering are turning to autoimmune disease as the sixth plank of their multibillion-dollar, 10-program ...

Charles River Laboratories International, Inc. CRL and Valo Health, Inc. recently announced an advanced product candidate for the treatment of different forms of lupus and other autoimmune ...

Charles River and Valo Health announce the identification of an advanceable product candidate for treatment of lupus and other autoimmune diseases.

Charles River and Valo Health identify a potential therapeutic for lupus using their combined offering, Logica.

“Together with our partners at Valo Health and through our ongoing collaboration with Flagship’s Pioneering Medicines, we look forward to further leveraging the power of Logica to advance this ...

Valo Health, Inc. (“Valo”), a biotechnology company focused on transforming the drug discovery and development process using human-centric data and artificial intelligence (AI), today ...

Valo Health, Inc. ("Valo"), a biotechnology company focused on transforming the drug discovery and development process using human-centric data and artificial intelligence (AI), today announced the ...